Formulation of Nanosuspensions of Albendazole for Oral Administration

E-ISSN： 1875-6786|4|1|53-58

ISSN： 1573-4137

Source： Current Nanoscience, Vol.4, Iss.1, 2008-02, pp. : 53-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Improved Bioavailability of Albendazole Following Oral Administration of Nanosuspension in Rats

Current Nanoscience, Vol. 3, Iss. 2, 2007-05 ,pp. : 191-194

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation of Nanosuspensions as a New Approach for the Delivery of Poorly Soluble Drugs

Current Nanoscience, Vol. 5, Iss. 4, 2009-11 ,pp. : 417-427

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation and In Vitro Evaluation of Gelatin Nanospheres for the Oral Delivery of Selegiline

Current Nanoscience, Vol. 9, Iss. 1, 2013-01 ,pp. : 21-25

Bentham Science Publishers

Access to resources Recommend Favorite

Formulation, Characterization and In Vivo Evaluation of Self-Nanoemulsifying Drug Delivery System for Oral Delivery of Valsartan

Current Nanoscience, Vol. 10, Iss. 2, 2014-04 ,pp. : 263-270

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle Formulation Increases Oral Bioavailability of Poorly Soluble Drugs: Approaches, Experimental Evidences and Theory

Current Nanoscience, Vol. 1, Iss. 3, 2005-11 ,pp. : 237-243

Bentham Science Publishers

Access to resources Recommend Favorite